The latest news from academia, regulators
research labs and other things of interest
Posted: Dec 12, 2014
Pulsing magnetic fields focus nanoparticles to deep targets
(Nanowerk News) Recent efforts between the University of Maryland (UMD) and Bethesda-based Weinberg Medical Physics LLC (WMP) have led to a new technique to magnetically deliver drug-carrying particles to hard-to-reach targets. The method has the potential to transform the way deep-tissue tumors and other diseases are treated.
UMD Fischell Department of Bioengineering (BioE) alumnus Dr. Aleksandar Nacev and BioE and Institute for Systems Research Professor Benjamin Shapiro have teamed up with WMP to exploit fast pulsed magnetic fields to focus nano-therapeutic magnetic particles to deep targets.
For years, researchers have worked with magnetic nano-particles loaded with therapies – such as drugs or genes – to develop noninvasive techniques to direct therapies and diagnostics to targets in the body. Magnetic nanoparticle research garnered media attention in October, when Google X (Google's innovation lab dedicated to furthering major technological advancements) announced its interest in the use of magnetic nano-particles for diagnostic applications.
Instead of surgery or systemically administered treatments, such as chemotherapy, the use of magnetic particles as drug carriers could potentially allow clinicians to use external electromagnets to focus therapy to the precise locations of a disease within a patient. However, until now, particles could only be attracted to a magnet, and thus could not be concentrated to points away from the magnet face. As a result, in prior clinical trials magnets held outside the body had only been able to concentrate treatment to targets at or just below the skin surface.
"What we have shown experimentally is that by exploiting the physics of nanorods we can use fast pulsed magnetic fields to focus the particles to a deep target between the magnets," Shapiro said.
These pulsed magnetic fields allowed the team to reverse the usual behavior of magnetic nano-particles. Instead of a magnet attracting the particles, they showed that an initial magnetic pulse can orient the rod-shaped particles without pulling them, and then a subsequent pulse can push the particles before the particles can reorient. By repeating the pulses in sequence, the particles were focused to locations deep between the electromagnets.
"The Holy Grail of magnetic drug targeting is the dream of using magnets outside the body to minimally-invasively direct drug therapy to anywhere inside the body, for example, to inoperable deep tumors or to sections of the brain that have been damaged by trauma, vascular or degenerative diseases," said Dr. Irving Weinberg, a practicing physician and the President of WMP. "We have shown that fast pulsing of external electromagnetic fields may be able to achieve this goal."
The study, published this week in Nano Letters ("Dynamic Inversion Enables External Magnets To Concentrate Ferromagnetic Rods to a Central Target") shows that, with appropriate external magnetic pulses, ferromagnetic particles carrying drugs or molecules could be concentrated to arbitrary deep locations between magnets. Nacev, Weinberg, Shapiro and their fellow researchers are now working to demonstrate this method in vivo to prove its therapeutic potential, in a project funded by the National Cancer Institute (NCI) Small Business Innovation Research program and featured at the NCI-sponsored Investor Conference in San Francisco. Additionally, the research team recently launched IronFocus Medical, Inc., a startup company established to commercialize their invention. More information about IronFocus Medical, Inc. is available online at www.ironfocusmedical.com.
"This technology could enable a new therapeutic modality that combines the spatial precision of traditional image-guided radiation with the biochemical specificity of molecular medicine," said Dr. John R. Adler, Vice President and Chief of New Clinical Applications for Varian Medical Systems.